Crown Electrokinetics Corp. short interest in 2021
In 2021, Crown Electrokinetics Corp.'s disclosed short interest ran from 0.16% of shares outstanding on 12 Feb 2021 to 0.65% on 31 Dec 2021, a change of +0.49 percentage points. The year's high was 1.29% on 30 Sep 2021 and its low 0.16% on 12 Feb 2021, averaging 0.73% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.95 days on 13 Aug 2021. Full history: Crown Electrokinetics Corp..
Cite this page
By year: 2021 · 2022 · 2023 · 2024
2021 in figures
- Start of year
- 0.16% (12 Feb 2021)
- End of year
- 0.65% (31 Dec 2021)
- Change
- +0.49 pp
- High
- 1.29% (30 Sep 2021)
- Low
- 0.16% (12 Feb 2021)
- Average
- 0.73%
- Highest days to cover
- 2.95 (13 Aug 2021)
- SEC filings marked
- 5
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Feb 2021 | 0.16% | 1.00 | |
| 26 Feb 2021 | 0.26% | 1.00 | 10-Q filed |
| 15 Mar 2021 | 0.52% | 1.00 | |
| 31 Mar 2021 | 0.80% | 1.00 | |
| 15 Apr 2021 | 0.88% | 1.45 | |
| 30 Apr 2021 | 1.05% | 1.45 | |
| 14 May 2021 | 0.75% | 1.57 | |
| 28 May 2021 | 0.63% | 1.66 | |
| 15 Jun 2021 | 0.62% | 1.00 | |
| 30 Jun 2021 | 0.87% | 1.27 | 10-K filed |
| 15 Jul 2021 | 0.79% | 1.98 | |
| 30 Jul 2021 | 0.65% | 1.94 | |
| 13 Aug 2021 | 0.70% | 2.95 | |
| 31 Aug 2021 | 0.72% | 1.57 | 10-Q filed |
| 15 Sep 2021 | 0.76% | 2.67 | |
| 30 Sep 2021 | 1.29% | 1.00 | |
| 15 Oct 2021 | 1.03% | 1.44 | |
| 29 Oct 2021 | 0.85% | 2.22 | |
| 15 Nov 2021 | 0.75% | 1.62 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 0.76% | 1.95 | |
| 15 Dec 2021 | 0.65% | 2.31 | |
| 31 Dec 2021 | 0.65% | 1.58 |
See also: Crown Electrokinetics Corp.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.